Article | January 5, 2026

Microbial Ingress No Longer An Effective CCI Test Method

By Oliver Stauffer and Tyler Harris, PTI

GettyImages-2173467777-vials-pharmaceutical-gloved-hands

Microbial ingress testing has long been considered a standard for container closure integrity (CCI), but evolving scientific understanding and regulatory expectations reveal its limitations. This method, which relies on detecting microbial contamination as a proxy for closure integrity, is inherently variable and lacks the sensitivity required for modern risk-based quality assurance. Factors such as microbial behavior, environmental conditions, and test reproducibility introduce uncertainty, making it an unreliable indicator of true CCI performance. Today, advanced deterministic methods offer more precise, validated approaches that align with regulatory guidance and industry best practices. Transitioning away from microbial ingress testing is critical for ensuring product sterility and patient safety.

Explore why this shift is necessary and what alternatives provide robust, science-driven assurance.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

PTI Packaging and Inspection Systems